In a significant move to enhance brand visibility and outreach, Lenz Therapeutics has launched its 'Make It Vizzable' campaign, featuring renowned actress and produc ...

LENZ Therapeutics and Lunatus Marketing & Consulting FZCO recently announced an exclusive agreement for Lunatus to register ...

EDOF technology, previously used in intraocular lenses, is now available in contact lenses, offering significant improvements ...

The optical formula for IOL presbyopia correction is a familiar one. It is no different than the formula for a successful spectacle presbyopia correction — emmetropia plus the reading “add.” ...

Please provide your email address to receive an email when new articles are posted on . Presbyopia is defined as a progressive decay in accommodation related to the physiological aging process of the ...

For many farsighted people, having different pairs of glasses for different viewing distances has been the norm. But with new technology, one pair of glasses could do the trick. Adaptive liquid ...

Presbyopia is an age-related medical condition whereby a person loses the ability to see objects at near distance clearly. Everyone will develop presbyopia at some point in their lives. Even if one ...

The first FDA-approved eye drops to treat age-related blurry near vision (presbyopia) has gone on sale in the US, offering a potential alternative to reading glasses for the estimated 128 million ...

Squinting while texting? Always losing your reading glasses? An eye implant that takes about 10 minutes to put in place is the newest procedure to correct the blurry, close-up vision that comes with ...

This page lists all known medications that could potentially lead to 'Presbyopia' as a side effect. It's important to note that mild side effects are quite common with medications. The medication(s) ...

The Companies plan to file an application with the FDA in the second half of 2025. Topline data were announced from a phase 3 trial evaluating MR-141 (phentolamine ophthalmic solution 0.75%) for the ...

Achieved approximately $1.6 million in net product revenue with over 20,000 prescriptions filled in Q4 2025 SAN DIEGO, Jan. 07, 2026 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” ...